Volume 29, Number 10—October 2023
Research
Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States
Table 2
Multivariable log-binomial regression of characteristics for 333 persons from 25 US jurisdictions who were diagnosed with TB–COVID-19 in 2020 and persons with TB only diagnosed in 2017‒2019 or in 2020*
Characteristic | 2020 TB only |
2017‒2019 TB only |
|||
---|---|---|---|---|---|
uPR (95% CI) | aPR (95% CI) | uPR (95% CI) | aPR (95% CI) | ||
Race/ethnicity† | |||||
White | Referent | Referent | Referent | Referent | |
Black | 0.8 (0.6‒1.1) | 1.1 (0.7‒1.7) | 0.9 (0.6‒1.1) | 1.2 (0.7‒1.9) | |
Asian | 0.7 (0.6‒0.9) | 0.8 (0.5‒1.2) | 0.7 (0.6‒0.9) | 0.8 (0.5‒1.3) | |
Hispanic | 1.6 (1.3‒2.0) | 1.4 (0.9‒2.2) | 1.6 (1.3‒1.9) | 1.4 (0.9‒2.2) | |
NHOPI | 2.4 (1.1‒5.4) | 2.3 (1.0‒5.3) | 2.2 (0.9‒5.2) | 2.9 (1.1‒7.4) | |
American Indian/Alaska Native |
3.4 (1.4‒8.1) |
5.3 (2.1‒13.4) |
2.3 (0.9‒6.0) |
3.4 (1.2‒9.6) |
|
Origin of birth | |||||
US-born | Referent | Referent | Referent | Referent | |
Non–US-born |
1.4 (1.1‒1.8) |
1.5 (1.1‒2.1) |
1.5 (1.1‒1.9) |
1.6 (1.1‒2.2) |
|
AFB sputum smear result | |||||
Negative | Referent | NI | Referent | Referent | |
Positive | 1.3 (1.0‒1.5) | 1.4 (1.1‒1.7) | 1.3 (1.0‒1.6) | ||
Missing/Unknown |
0.9 (0.7‒1.2) |
0.9 (0.7‒1.2) |
1.0 (0.7‒1.5) |
||
Long-term care resident at TB diagnosis‡ | |||||
No | Referent | Referent | Referent | Referent | |
Yes |
2.6 (1.6‒4.2) |
2.5 (1.6‒4.0) |
2.5 (1.5‒4.1) |
2.4 (1.4‒4.0) |
|
Diabetes | |||||
No | Referent | Referent | Referent | Referent | |
Yes |
1.8 (1.4‒2.2) |
1.6 (1.3‒2.0) |
2.0 (1.6‒2.5) |
1.8 (1.4‒2.2) |
|
End-stage renal disease | |||||
No | Referent | NI | Referent | Referent | |
Yes | 1.8 (1.2‒2.7) | 2.2 (1.4‒3.4) | 1.7 (1.1‒2.7) |
*Model adjusted for other variables in the table. aPR, adjusted prevalence ratio; AFB, acid-fast bacilli; NHOPI, Native Hawaiian and Other Pacific Islander; NI, not included in adjusted regression model because not statistically significant at 95% confidence level; TB, tuberculosis; TB–COVID-19, diagnosed with both TB and COVID-19 within 180 days; uPR, unadjusted prevalence ratio. †Multiple race category not included because no persons with TB–COVID-19 reported multiple races. ‡Among persons >15 years of age.
1Group members are listed at the end of this article.